Secretary Robert F. Kennedy Jr. said he is considering a “regulatory framework” for Medicare and Medicaid to cover GLP-1 ...

A new study finds the use of weight loss drugs like Ozempic, Wegovy, and Zepbound in people with Type-1 Diabetes has risen ...

Nerve injury, or neuropathy, affects millions globally and is difficult to treat. It often causes symptoms like tingling, ...

The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

This popular spice is beloved by many, but its potential interactions with certain medications are important to be aware of.

Advocates for publicly funded coverage say there are detrimental and deadly health consequences for patients who cannot ...